West Pharmaceutical Services WST Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
Based on the most recent quarter.
The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's current ratio?
- West Pharmaceutical Services (WST) reported current ratio of 2.7× in Q1 2026.
- How has West Pharmaceutical Services's current ratio changed year-over-year?
- West Pharmaceutical Services's current ratio decreased by 2.1% year-over-year, from 2.8× to 2.7×.
- What is the long-term trend for West Pharmaceutical Services's current ratio?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's current ratio has grown at a -0.5% compound annual growth rate (CAGR), from 11.7× to 11.4×.
- What does current ratio mean?
- Whether the company has enough short-term assets to cover its short-term bills.
- How do you interpret current ratio?
- Above 1.0 means short-term assets cover short-term liabilities. Very high values can signal idle cash or bloated inventory/receivables rather than strength — there's a healthy middle, not 'more is better'.
- How does current ratio compare across companies?
- Comparable within an industry. Working-capital-light businesses can operate safely below 1.0 by collecting before they pay.